申请人:CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
公开号:US10800765B2
公开(公告)日:2020-10-13
The present application discloses an indole as represented by formula (I) used as a CRTH2 inhibitor, and a pharmaceutically acceptable salt or tautomer of the indole, and an application of same in treating a disease related to a CRTH2 receptor.
本申请公开了一种由式(I)表示的用作 CRTH2 抑制剂的吲哚、该吲哚的药学上可接受的盐或同系物,以及其在治疗与 CRTH2 受体有关的疾病中的应用。